Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Calabrese

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Transactions of the American Neurological Association|January 1, 1978
CSF infusion test in pseudotumor cerebriV P Calabrese, J B Selhorst, J W Harbison
Schizophrenia Research|February 1, 1994
Brain structure changes in schizophrenics with high serum titers of antibodies to herpes virusA K Pandurangi, A L Pelonero, L Nadel, et al.
Journal of Lipid Research|February 1, 1981
Lipid composition of axolemma-enriched fractions from human brainsG H DeVries, W J Zetusky, C Zmachinski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 11, 1998
Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseasesJ A Rawes, V P Calabrese, O A Khan, et al.
Neurology|September 1, 1979
Psuedotumor cerebri and insecticide intoxicationG E Sanborn, J B Selhorst, V P Calabrese, et al.
Journal of Clinical and Experimental Neuropsychology|July 22, 1998
Vigilance performance in Parkinson's disease and depressionR P Hart, J B Wade, V P Calabrese, et al.
Epilepsia|November 1, 1991
Cerebrospinal fluid lactate levels and prognosis in status epilepticusV P Calabrese, H D Gruemer, K James, et al.
Neurology|June 1, 1981
Suppressor cell activity in multiple sclerosisW C Wallen, S A Houff, M Iivanainen, et al.
Neuroscience Letters|January 20, 1981
Enzyme-linked immunosorbent assay (ELISA) for antibodies to human myelin and axolemma-enriched fractionsV P Calabrese, W Wallen, G Castellano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 1998
N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonismV P Calabrese, K A Lloyd, P Brancazio, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Transactions of the American Neurological Association|January 1, 1978
CSF infusion test in pseudotumor cerebriV P Calabrese, J B Selhorst, J W Harbison
Schizophrenia Research|February 1, 1994
Brain structure changes in schizophrenics with high serum titers of antibodies to herpes virusA K Pandurangi, A L Pelonero, L Nadel, et al.
Journal of Lipid Research|February 1, 1981
Lipid composition of axolemma-enriched fractions from human brainsG H DeVries, W J Zetusky, C Zmachinski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 11, 1998
Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseasesJ A Rawes, V P Calabrese, O A Khan, et al.
Neurology|September 1, 1979
Psuedotumor cerebri and insecticide intoxicationG E Sanborn, J B Selhorst, V P Calabrese, et al.
Journal of Clinical and Experimental Neuropsychology|July 22, 1998
Vigilance performance in Parkinson's disease and depressionR P Hart, J B Wade, V P Calabrese, et al.
Epilepsia|November 1, 1991
Cerebrospinal fluid lactate levels and prognosis in status epilepticusV P Calabrese, H D Gruemer, K James, et al.
Neurology|June 1, 1981
Suppressor cell activity in multiple sclerosisW C Wallen, S A Houff, M Iivanainen, et al.
Neuroscience Letters|January 20, 1981
Enzyme-linked immunosorbent assay (ELISA) for antibodies to human myelin and axolemma-enriched fractionsV P Calabrese, W Wallen, G Castellano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 2, 1998
N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonismV P Calabrese, K A Lloyd, P Brancazio, et al.
Pageof 3